Mirae Asset Global ETFs Holdings
ACRS icon

Mirae Asset Global ETFs Holdings’s Aclaris Therapeutics ACRS Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$163K Buy
43,589
+1,021
+2% +$3.44K ﹤0.01% 2455
2025
Q4 		$128K Sell
42,568
-187
-0.4% -$472 ﹤0.01% 2561
2025
Q3 		$81.2K Sell
42,755
-6,867
-14% -$12K ﹤0.01% 2756
2025
Q2 		$70.5K Buy
+49,622
New +$67.1K ﹤0.01% 2769
2024
Q3 		– Sell
-35,794
Closed -$39.4K – 3071
2024
Q2 		$39.4K Buy
+35,794
New +$42.1K ﹤0.01% 2839

Other funds holding ACRS

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ACRS Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Aclaris Therapeutics (ACRS) stake by 2.4% in Q1 2026, buying an estimated $3.44K and bringing the position to 43,589 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #2455.

Mirae Asset Global ETFs Holdings first reported a position in ACRS in Q2 2024 and has held it in 5 quarters since. 136 funds tracked by Wall St. Rank hold ACRS as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 43,589 shares of Aclaris Therapeutics worth $163K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 1,021 Aclaris Therapeutics shares in Q1 2026, an estimated $3.44K.
  • Aclaris Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2455 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Aclaris Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • 136 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.